An audit of surgical management of gastrointestinal stromal tumours (GIST)
- 30 April 2006
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 32 (3) , 310-314
- https://doi.org/10.1016/j.ejso.2005.11.021
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Prognostic factors after surgery of primary resectable gastrointestinal stromal tumoursEuropean Journal of Surgical Oncology, 2004
- Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trialThe Lancet, 2004
- Surgery and Imatinib in the Management of GIST: Emerging Approaches to Adjuvant and Neoadjuvant TherapyAnnals of Surgical Oncology, 2004
- Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) eraSurgery, 2003
- Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumoursBritish Journal of Surgery, 2003
- Overview of issues related to imatinib therapy of advanced gastrointestinal stromal tumors: a discussion among the expertsEuropean Journal Of Cancer, 2002
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Gastrointestinal Stromal Tumors and Leiomyosarcoma of the Abdomen and Retroperitoneum: A Clinical ComparisonAnnals of Surgical Oncology, 2001
- The Effect of Surgery and Grade on Outcome of Gastrointestinal Stromal TumorsArchives of Surgery, 2001
- Smooth muscle tumours of the digestive tract: Report of 160 casesBritish Journal of Surgery, 1988